Literature DB >> 7831816

The human foamy virus internal promoter is required for efficient gene expression and infectivity.

M Löchelt1, S F Yu, M L Linial, R M Flügel.   

Abstract

The human foamy or spumaretrovirus (HFV) is a complex retrovirus that codes for the three retroviral genes gag, pol, and env and the regulatory and accessory bel genes. A particular feature of HFV gene expression was recently described: not only does the HFV provirus contain the classical retroviral long terminal repeat promoter, a second functionally active promoter is present in the env gene upstream of the bel genes (M. Löchelt, W. Muranyi, and R. M. Flügel, 1993, Proc. Natl. Acad. Sci. USA 90, 7317-7321). Both, the HFV long terminal repeat promoter I and internal promoter II depend upon the HFV transcriptional transactivator Bel 1 for efficient gene expression. The internal promoter directs the synthesis of functionally active Bel 1 transactivator and Bet proteins that are expressed early after HFV infection. In this report, it is shown that mutation of the promoter II TATA box resulted in HFV proviral clones with a reduction in infectivity by a factor of approximately 100. Gene expression by promoter II TATA box mutant HFV proviruses was reduced. HFV proviruses with the mutated promoter II TATA box used cryptic start sites of transcription upstream of the original promoter II TATA box, resulting in an inefficient and less accurate transcriptional initiation. The reduced HFV structural gene expression by the mutated HFV proviruses was relieved by providing Bel 1 protein in trans. This demonstrates that HFV promoter II-directed Bel 1 expression is important for producing the high levels of Bel 1 that increases virus replication.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7831816     DOI: 10.1016/s0042-6822(95)80077-8

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  29 in total

Review 1.  Molecular biology of foamy viruses.

Authors:  Axel Rethwilm
Journal:  Med Microbiol Immunol       Date:  2010-05-06       Impact factor: 3.402

2.  Functional characterization of the bovine foamy virus miRNA expression cassette and its dumbbell-shaped pri-miRNA.

Authors:  Wenhu Cao; Anke Heit; Agnes Hotz-Wagenblatt; Martin Löchelt
Journal:  Virus Genes       Date:  2018-05-31       Impact factor: 2.332

Review 3.  Foamy viruses are unconventional retroviruses.

Authors:  M L Linial
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

4.  Induction of cellular genes is mediated by the Bel1 transactivator in foamy virus-infected human cells.

Authors:  A Wagner; A Doerks; M Aboud; A Alonso; T Tokino; R M Flügel; M Löchelt
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

5.  Cell-type-specific regulation of the two foamy virus promoters.

Authors:  C D Meiering; C Rubio; C May; M L Linial
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

6.  Active foamy virus proteinase is essential for virus infectivity but not for formation of a Pol polyprotein.

Authors:  J Konvalinka; M Löchelt; H Zentgraf; R M Flügel; H G Kräusslich
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

7.  Mouse mammary tumor virus superantigen expression in B cells is regulated by a central enhancer within the pol gene.

Authors:  F U Reuss; J M Coffin
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

8.  Derivation and functional characterization of a consensus DNA binding sequence for the tas transcriptional activator of simian foamy virus type 1.

Authors:  Y Kang; B R Cullen
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

9.  The human foamy virus Bel-1 transcription factor is a sequence-specific DNA binding protein.

Authors:  F He; W S Blair; J Fukushima; B R Cullen
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

10.  Molecular characterization of proteolytic processing of the Pol proteins of human foamy virus reveals novel features of the viral protease.

Authors:  K I Pfrepper; H R Rackwitz; M Schnölzer; H Heid; M Löchelt; R M Flügel
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.